
Crystal Pharmatech, founded in 2010, specializes in solid-state and formulation science, transforming drug molecules into clinically viable medicines. With a global footprint across four R&D centers and cGMP facilities that meet FDA, EMA, and NMPA standards, the company offers end-to-end services—from salt, polymorph, and cocrystal screening to amorphous solid dispersion, formulation development, and GMP manufacturing. Their proprietary Mol2Med™ program accelerates small-molecule candidates through a three-step, first-time-right pathway, ensuring robust API forms and scalable processes for clinical and commercial production. By integrating scientific rigor, precision manufacturing, and collaborative expertise, Crystal Pharmatech delivers reliable, compliant solutions that streamline drug development from discovery to market.
Crystal Bio Solutions is a CRO providing global-standard services in GLP/GCLP bioanalysis and biomarker. Our clients include multinational pharmaceutical companies and biotech companies. The role is responsible for providing bioanalytical support for both pre-clinical and clinical projects and partnering with our clients for project success.
Crystal Pharmatech, founded in 2010, specializes in solid-state and formulation science, transforming drug molecules into clinically viable medicines. With a global footprint across four R&D centers and cGMP facilities that meet FDA, EMA, and NMPA standards, the company offers end-to-end services—from salt, polymorph, and cocrystal screening to amorphous solid dispersion, formulation development, and GMP manufacturing. Their proprietary Mol2Med™ program accelerates small-molecule candidates through a three-step, first-time-right pathway, ensuring robust API forms and scalable processes for clinical and commercial production. By integrating scientific rigor, precision manufacturing, and collaborative expertise, Crystal Pharmatech delivers reliable, compliant solutions that streamline drug development from discovery to market.